SORAFENIB
sorafenib 200 mg tablet, 60
SORAFENIB (10242C)
10242C
Manner of administration:Oral
Restriction (Streamlined authority code: 7487)
Indication: Stage IV clear cell variant renal cell carcinoma (RCC)
Treatment phase: Continuing treatment beyond 3 months
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 120 | # of repeats: 5 | DPMQ: $4,150.34 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Nexavar | |||||